文献速递甲状腺疾病

诊断年龄在定义家族性非髓样甲状腺癌中的作用

Role of Age at Diagnosis in Defining Potential Familial Nonmedullary Thyroid Cancer in Kindreds With Two Affected Members.
PubMed 文献 · J Clin Endocrinol Metab · 2021-01-01

研究基于721例乳头状甲状腺癌(PTC)患者,识别出95例有两个一级亲属患病的家族性PTC(FPTC)患者,按诊断年龄≤45岁或>45岁分组,与626例散发性PTC(SPTC)比较临床病理特征和结局。结果显示诊断年龄≤45岁的FPTC患者较匹配的SPTC患者更多见多灶、双侧和甲状腺外侵犯且结局更差,而>45岁组无差异。多因素分析中远处转移、ATA风险和FPTC≤45岁是结局的独立预测因素。

要点

  • 两个一级亲属患PTC且均诊断年龄≤45岁时,肿瘤侵袭性更强、结局更差。
  • 诊断年龄>45岁的家族性与散发性PTC患者临床病理特征无差异。
  • 建议在定义两个受累成员的家族性PTC时纳入诊断年龄作为关键要素。

核心结论

  • 当两个家庭成员均诊断PTC且年龄<45岁时,PTC更具侵袭性,建议家族性PTC定义中考虑诊断年龄。

研究设计与样本

  • 从721例PTC患者中识别95例有两个一级亲属的家族性PTC患者,分为诊断年龄≤45岁组和>45岁组,与626例散发性PTC患者比较。

主要发现

  • 诊断年龄≤45岁的家族性PTC患者较匹配的散发性PTC患者更常见多灶、双侧和甲状腺外侵犯,且结局更差。
  • 诊断年龄>45岁的家族性与散发性PTC患者之间无差异。
  • 多因素分析显示远处转移、ATA风险和FPTC≤45岁是结局的独立预测因素。

关键数值与推荐

  • 家族性PTC患者诊断年龄≤45岁(两个一级亲属均受累)与散发性PTC相比,多灶、双侧、甲状腺外侵犯更频繁且结局更差。
  • 多因素分析中FPTC≤45岁是结局的独立预测因素。

临床怎么用

  • 对于两个一级亲属患PTC且诊断年龄均≤45岁的家族,应视为高风险家族性PTC,加强监测和积极管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: The definition of familial nonmedullary thyroid cancer (FNMTC) in 2 or more first-degree relatives is controversial due to the high probability of observing a sporadic association when only 2 members of first-degree relatives are affected. OBJECTIVE: To evaluate the role of age at diagnosis in differentiating the true cases of FNMTC. DESIGN, SETTING, PARTICIPANTS, AND MAIN OUTCOME: From a group of 721 papillary thyroid cancer (PTC) patients, 95 familial PTC (FPTC) patients with 2 first-degree relatives have been identified. They were split in 2 groups: Group 1 consisted of both the proband and the affected relative, with age at diagnosis ≤ 45 years; Group 2 consisted of proband and/or the affected family member, with age at diagnosis > 45 years. The clinical-pathological features and outcome of both FPTC groups were compared with 626 sporadic PTC patients (SPTC). RESULTS: Familial PTC patients with age at diagnosis ≤ 45 years, compared with the matched group of sporadic PTCs, had a more frequent multifocal, bilateral, and extrathyroidal extension of tumor and showed worse outcome. No differences were found between FPTC and SPTC patients with age > 45 years. At multivariate analysis, distant metastases, American Thyroid Association (ATA) risk, and FPTC ≤ 45 years were independent predictors of outcome. CONCLUSIONS: Based on the observation that PTC is more aggressive when the diagnosis is made in 2 family members, both with age < 45years, we suggest that the definition of FPTC in kindreds with 2 affected members should also take into account the age at diagnosis as a key element of familial cancer.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Capezzone M, Sagnella A, Pilli T, et al. Role of Age at Diagnosis in Defining Potential Familial Nonmedullary Thyroid Cancer in Kindreds With Two Affected Members. J Clin Endocrinol Metab. 2021. PMID: 33175120. doi:10.1210/clinem/dgaa798

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。